Spis treści:
RAPORT BIEŻĄCYMESSAGE (ENGLISH VERSION)
INFORMACJE O PODMIOCIE
PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ
| KOMISJA NADZORU FINANSOWEGO | ||||||||||||
|
| Raport bieżący nr | 13 | / | 2023 | ||||||||
| Data sporządzenia: | 2023-11-28 | |||||||||||
| Skrócona nazwa emitenta | ||||||||||||
| MILESTONE MEDICAL | ||||||||||||
| Temat | ||||||||||||
| Entering into agreement with Bioline Supply to distribute the CompuFlo Epidural System and related disposables across Spain | ||||||||||||
| Podstawa prawna | ||||||||||||
| Art. 17 ust. 1 MAR - informacje poufne. | ||||||||||||
| Treść raportu: | ||||||||||||
| The Board of Directors of Milestone Medical Inc. (WAR: MMD, “the Company", “the Issuer"), today announced that it entered into an agreement with Bioline Supply to distribute the CompuFlo® Epidural System and related disposables in Spain. In connection with the agreement, the Company commenced sales and shipments of its CompuFlo Epidural Instrument and consumables to Spain. Founded in 2000, Bioline Supply is a supplier of medical devices and equipment, supporting many hospitals and pain clinics across Spain, with a specialized presence in certain medical disciplines, including anesthesiology, surgery, and non-vascular intervention. The Board of Directors of the Company is pleased to enter into this distribution agreement with Bioline Supply and believes that Spain represents an important market for us with a population in excess of 48 million people and a growing number of epidural procedures each year in pain management and anesthesiology. Bioline Supply and its principals have extensive relationships with physicians, pain clinics and hospitals, as well as a proven track record of introducing new medical devices in Spain, which should be invaluable as the Company seeks to expand its European and international market presence. | ||||||||||||
MESSAGE (ENGLISH VERSION) | |||
|
| |||
| MILESTONE MEDICAL INC | ||||||||||||||||
| (pełna nazwa emitenta) | ||||||||||||||||
| MILESTONE MEDICAL | ||||||||||||||||
| (skrócona nazwa emitenta) | (sektor wg. klasyfikacji GPW w W-wie) | |||||||||||||||
| NJ 07039 | . | |||||||||||||||
| (kod pocztowy) | (miejscowość) | |||||||||||||||
| South Orange Avenue Livingston | 220 | |||||||||||||||
| (ulica) | (numer) | |||||||||||||||
| +11 973 535 2717 | +11 973 535 2829 | |||||||||||||||
| (telefon) | (fax) | |||||||||||||||
| (e-mail) | (www) | |||||||||||||||
| 27-5484393 | ||||||||||||||||
| (NIP) | (REGON) | |||||||||||||||
| PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ | |||||
| Data | Imię i Nazwisko | Stanowisko/Funkcja | Podpis | ||
| 2023-11-28 | Keisha Harcum | Controller | Keisha Harcum | ||
